Literature DB >> 27651412

Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.

Gary Wong1, Xiangguo Qiu2, Marc-Antoine de La Vega3, Lisa Fernando4, Haiyan Wei4, Alexander Bello2, Hugues Fausther-Bovendo4, Jonathan Audet2, Andrea Kroeker4, Robert Kozak4, Kaylie Tran4, Shihua He4, Kevin Tierney4, Geoff Soule4, Estella Moffat5, Stephan Günther6, George F Gao7, Jim Strong4, Carissa Embury-Hyatt5, Gary Kobinger8.   

Abstract

Enhanced virulence and/or transmission of West African Ebola virus (EBOV) variants, which are divergent from their Central African counterparts, are suspected to have contributed to the sizable toll of the recent Ebola virus disease (EVD) outbreak. This study evaluated the pathogenicity and shedding in rhesus macaques infected with 1 of 2 West African isolates (EBOV-C05 or EBOV-C07) or a Central African isolate (EBOV-K). All animals infected with EBOV-C05 or EBOV-C07 died of EVD, whereas 2 of 3 EBOV-K-infected animals died. The viremia level was elevated 10-fold in EBOV-C05-infected animals, compared with EBOV-C07- or EBOV-K-infected animals. More-severe lung pathology was observed in 2 of 6 EBOV-C05/C07-infected macaques. This is the first detailed analysis of the recently circulating EBOV-C05/C07 in direct comparison to EBOV-K with 6 animals per group, and it showed that EBOV-C05 but not EBOV-C07 can replicate at higher levels and cause more tissue damage in some animals. Increased virus shedding from individuals who are especially susceptible to EBOV replication is possibly one of the many challenges facing the community of healthcare and policy-making responders since the beginning of the outbreak. © Crown copyright 2016.

Entities:  

Keywords:  Ebola virus; Kikwit; Makona; nonhuman primates; pathogenicity

Mesh:

Year:  2016        PMID: 27651412      PMCID: PMC5050479          DOI: 10.1093/infdis/jiw267

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  The SARS outbreak in a general hospital in Tianjin, China -- the case of super-spreader.

Authors:  Sh X Wang; Y M Li; B C Sun; S W Zhang; W H Zhao; M T Wei; K X Chen; X L Zhao; Z L Zhang; M Krahn; A C Cheung; P P Wang
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Hilary Staples; Jerritt W Nunneley; Anysha Ticer; Edward J Dick; Michael A Owston; Christopher Reed; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

Review 4.  Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.

Authors:  E M Leroy; J-P Gonzalez; S Baize
Journal:  Clin Microbiol Infect       Date:  2011-07       Impact factor: 8.067

5.  Reduced vaccination and the risk of measles and other childhood infections post-Ebola.

Authors:  Saki Takahashi; C Jessica E Metcalf; Matthew J Ferrari; William J Moss; Shaun A Truelove; Andrew J Tatem; Bryan T Grenfell; Justin Lessler
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

6.  EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.

Authors:  Andrea Marzi; Shelly J Robertson; Elaine Haddock; Friederike Feldmann; Patrick W Hanley; Dana P Scott; James E Strong; Gary Kobinger; Sonja M Best; Heinz Feldmann
Journal:  Science       Date:  2015-08-06       Impact factor: 47.728

7.  Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.

Authors:  Andrea Marzi; Friederike Feldmann; Patrick W Hanley; Dana P Scott; Stephan Günther; Heinz Feldmann
Journal:  Emerg Infect Dis       Date:  2015-10       Impact factor: 6.883

8.  Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.

Authors:  Emily P Thi; Chad E Mire; Amy C H Lee; Joan B Geisbert; Joy Z Zhou; Krystle N Agans; Nicholas M Snead; Daniel J Deer; Trisha R Barnard; Karla A Fenton; Ian MacLachlan; Thomas W Geisbert
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

Review 9.  Transmission of Ebola viruses: what we know and what we do not know.

Authors:  Michael T Osterholm; Kristine A Moore; Nicholas S Kelley; Lisa M Brosseau; Gary Wong; Frederick A Murphy; Clarence J Peters; James W LeDuc; Phillip K Russell; Michel Van Herp; Jimmy Kapetshi; Jean-Jacques T Muyembe; Benoit Kebela Ilunga; James E Strong; Allen Grolla; Anja Wolz; Brima Kargbo; David K Kargbo; David Avram Sanders; Gary P Kobinger
Journal:  mBio       Date:  2015-02-19       Impact factor: 7.867

10.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962

View more
  17 in total

Review 1.  Clinical Evaluation of Ebola Virus Disease Therapeutics.

Authors:  Guodong Liu; Gary Wong; Shuo Su; Yuhai Bi; Frank Plummer; George F Gao; Gary Kobinger; Xiangguo Qiu
Journal:  Trends Mol Med       Date:  2017-08-17       Impact factor: 11.951

2.  The Makona Variant of Ebola Virus Is Highly Lethal to Immunocompromised Mice and Immunocompetent Ferrets.

Authors:  Gary Wong; Anders Leung; Shihua He; Wenguang Cao; Marc-Antoine De La Vega; Bryan D Griffin; Geoff Soule; Gary P Kobinger; Darwyn Kobasa; Xiangguo Qiu
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

3.  Long-Range Polymerase Chain Reaction Method for Sequencing the Ebola Virus Genome From Ecological and Clinical Samples.

Authors:  Stephanie N Seifert; Jonathan E Schulz; M Jeremiah Matson; Trenton Bushmaker; Andrea Marzi; Vincent J Munster
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

4.  Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models.

Authors:  Andrea Marzi; Spencer Chadinah; Elaine Haddock; Friederike Feldmann; Nicolette Arndt; Cynthia Martellaro; Dana P Scott; Patrick W Hanley; Tolbert G Nyenswah; Samba Sow; Moses Massaquoi; Heinz Feldmann
Journal:  Cell Rep       Date:  2018-05-08       Impact factor: 9.423

5.  Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient.

Authors:  Mirella Biava; Claudia Caglioti; Licia Bordi; Concetta Castilletti; Francesca Colavita; Serena Quartu; Emanuele Nicastri; Francesco Nicola Lauria; Nicola Petrosillo; Simone Lanini; Thomas Hoenen; Gary Kobinger; Alimuddin Zumla; Antonino Di Caro; Giuseppe Ippolito; Maria Rosaria Capobianchi; Eleonora Lalle
Journal:  PLoS Pathog       Date:  2017-01-05       Impact factor: 6.823

Review 6.  Animal models for filovirus infections.

Authors:  Vinayakumar Siragam; Gary Wong; Xiang-Guo Qiu
Journal:  Zool Res       Date:  2018-01-18

7.  Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model.

Authors:  Richard S Bennett; James Logue; David X Liu; Rebecca J Reeder; Krisztina B Janosko; Donna L Perry; Timothy K Cooper; Russell Byrum; Danny Ragland; Marisa St Claire; Ricky Adams; Tracey L Burdette; Tyler M Brady; Kyra Hadley; M Colin Waters; Rebecca Shim; William Dowling; Jing Qin; Ian Crozier; Peter B Jahrling; Lisa E Hensley
Journal:  Viruses       Date:  2020-07-14       Impact factor: 5.048

8.  Development of a Lethal Intranasal Exposure Model of Ebola Virus in the Cynomolgus Macaque.

Authors:  Kendra J Alfson; Laura E Avena; Gabriella Worwa; Ricardo Carrion; Anthony Griffiths
Journal:  Viruses       Date:  2017-10-29       Impact factor: 5.048

9.  Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.

Authors:  Ronald B Reisler; Chenggang Yu; Michael J Donofrio; Travis K Warren; Jay B Wells; Kelly S Stuthman; Nicole L Garza; Sean A Vantongeren; Ginger C Donnelly; Christopher D Kane; Mark G Kortepeter; Sina Bavari; Anthony P Cardile
Journal:  Emerg Infect Dis       Date:  2017-08       Impact factor: 6.883

10.  Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection.

Authors:  Emily Speranza; Ignacio Caballero; Anna N Honko; Joshua C Johnson; J Kyle Bohannon; Lisa Evans DeWald; Dawn M Gerhardt; Jennifer Sword; Lisa E Hensley; Richard S Bennett; John H Connor
Journal:  mBio       Date:  2020-06-16       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.